Evidence map›Paper›PMID 38822070›Full record

ArticleScientific reports2024

Nowcasting methods to improve the performance of respiratory sentinel surveillance: lessons from the COVID-19 pandemic.

Sandra Flores-Alvarado, María Fernanda Olivares, Natalia Vergara, Christian García, Mauricio Canals, Cristóbal Cuadrado

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sandra Flores-AlvaradoEscuela de Salud Pública, Facultad de Medicina, Universidad de Chile, Av. Independencia 939, Santiago, Chile.
María Fernanda OlivaresDepartamento de Epidemiología, Subsecretaría de Salud Pública, Ministerio de Salud de Chile, Santiago, Chile.
Natalia VergaraDepartamento de Epidemiología, Subsecretaría de Salud Pública, Ministerio de Salud de Chile, Santiago, Chile.
Christian GarcíaDepartamento de Epidemiología, Subsecretaría de Salud Pública, Ministerio de Salud de Chile, Santiago, Chile.
Mauricio CanalsEscuela de Salud Pública, Facultad de Medicina, Universidad de Chile, Av. Independencia 939, Santiago, Chile.
Cristóbal CuadradoEscuela de Salud Pública, Facultad de Medicina, Universidad de Chile, Av. Independencia 939, Santiago, Chile. ccuadrado@uchile.cl.

Funding

Agencia Nacional de Investigación y Desarrollo ONICYT-PFCHA/Doctorado Nacional/2020-21200398
6 · The paper itself

Abstract

Respiratory diseases, including influenza and coronaviruses, pose recurrent global threats. This study delves into the respiratory surveillance systems, focusing on the effectiveness of SARI sentinel surveillance for total and severe cases incidence estimation. Leveraging data from the COVID-19 pandemic in Chile, we examined 2020-2023 data (a 159-week period) comparing census surveillance results of confirmed cases and hospitalizations, with sentinel surveillance. Our analyses revealed a consistent underestimation of total cases and an overestimation of severe cases of sentinel surveillance. To address these limitations, we introduce a nowcasting model, improving the precision and accuracy of incidence estimates. Furthermore, the integration of genomic surveillance data significantly enhances model predictions. While our findings are primarily focused on COVID-19, they have implications for respiratory virus surveillance and early detection of respiratory epidemics. The nowcasting model offers real-time insights into an outbreak for public health decision-making, using the same surveillance data that is routinely collected. This approach enhances preparedness for emerging respiratory diseases by the development of practical solutions with applications in public health.

Indexed as

COVID-19Sentinel SurveillanceChileHospitalizationHumansIncidencePandemicsSARS-CoV-2Emerging diseasesEpidemiological surveillanceILINowcastingPublic healthSARI

Identifiers

PMID38822070
PMCPMC11143190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.